Zepbound 2.5 MG/0.5 ML pen 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26FV878
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $13,787
Award facts
- Contract value 100% obligated
- $13,786.73 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a $13,786.73 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Zepbound (semaglutide) 2.5 mg/0.5 mL pens on January 29, 2026, with completion targeted for January 30, 2026. This delivery order was competitively awarded with no set-aside designation and represents a task order under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999.99 million through December 2031. The point of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters and serves as a critical pharmaceutical distributor for federal medical procurement.
AmerisourceBergen's contract portfolio with federal agencies demonstrates its substantial role in supplying pharmaceutical products and medical supplies to military and veteran healthcare systems. The company's $999.99 million IDC with DLA encompasses a comprehensive range of medical commodities, including specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains. This delivery order for Zepbound, an FDA-approved diabetes and weight management medication, exemplifies the company's capability to fulfill federal medical supply requirements for medications supporting military healthcare programs globally, including the Defense Health Agency and U.S. Coast Guard customers.
Quick answers
Who was awarded contract SPE2DR26FV878?
SPE2DR26FV878 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 29, 2026.
How much is contract SPE2DR26FV878 worth?
The government has obligated $13,787 on SPE2DR26FV878.
Is contract SPE2DR26FV878 an order under another contract?
Yes. SPE2DR26FV878 is a delivery order under SPE2DR25D1053, an indefinite delivery contract.
Was contract SPE2DR26FV878 competed?
The extent of competition for SPE2DR26FV878 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award